IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding IGC Pharma, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 25 | 25 | 0 |
| Shares | 2.36M | 2.56M | +204.0K (+8.7%) |
| Value | $943.4K | $1.11M | +$166.6K (+17.7%) |
New holders (5)
Institutions that held IGC Pharma, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 152,376 | $66.1K | 0.00% |
| Virtu Financial LLC | 46,497 | $20.0K | 0.00% |
| Commonwealth Equity Services, LLC | 34,600 | $15.0K | 0.00% |
| Bank of America Corp | 417 | $181 | 0.00% |
| Simplex Trading, LLC | 2,012 | $0 | 0.00% |
Sold out (5)
Institutions that held IGC Pharma, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Renaissance Technologies LLC | 141,303 | $57.0K |
| XTX Topco Ltd | 29,272 | $11.7K |
| Central Trust Co | 900 | $360 |
| Wells Fargo & Company | 379 | $152 |
| GWM Advisors LLC | 25 | $10 |